zeranol has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, HU; Dodge, JA; Glasebrook, AL; Magee, DE; Phillips, DL; Sato, M; Short, LL | 1 |
| Ishiwata, I; Koyama, T; Murata, H; Withanage, GS | 1 |
2 other study(ies) available for zeranol and Adenocarcinoma
| Article | Year |
|---|---|
Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat.
Topics: Adenocarcinoma; Animals; Anticholesteremic Agents; Benzhydryl Compounds; Binding, Competitive; Bone Density; Breast Neoplasms; Cell Line; Cholesterol; Coumestrol; Environmental Pollutants; Estradiol; Estrogens, Non-Steroidal; Female; Genistein; Humans; Isoflavones; Kinetics; Methoxychlor; Ovariectomy; Phenols; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Uterus; Zeranol | 1996 |
Agonistic and antagonistic effects of zearalenone, an etrogenic mycotoxin, on SKN, HHUA, and HepG2 human cancer cell lines.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Cell Division; Colorimetry; Dose-Response Relationship, Drug; Endometrial Neoplasms; Estradiol; Estrogens, Non-Steroidal; Female; Humans; Leiomyosarcoma; Tumor Cells, Cultured; Zearalenone; Zeranol | 2001 |